#chirality

Part 10: Stereochemistry in Pharmaceutical Sciences – Current Trends and Future Directions

“Beyond today – emerging trends shaping the future of stereochemistry in pharma” Introduction The landscape of stereochemistry in pharmaceutical sciences continues to evolve with scientific and technological advances. This final part looks at emerging trends and future challenges. These include: – New developments in asymmetric catalysis, such as organocatalysts (MacMillan/List catalysts) that have expanded the toolkit for chiral synthesis, and the 2021 Nobel recognition of this field – implying more green and metal-free asymmetric processes …

Part 10: Stereochemistry in Pharmaceutical Sciences – Current Trends and Future Directions Read More »

Part 9: Stereochemistry in Drug Discovery and Development

“From hit to lead to medicine – where stereochemistry shapes every stage of discovery” Introduction Stereochemistry is not only crucial in the final stages of drug production – it plays a significant role right from the discovery and lead optimization phases. In this part, we consider how medicinal chemists account for chirality when designing compounds and how structure-activity relationships (SAR) can depend on stereochemistry. We also look at how screening libraries incorporate stereochemical diversity, and …

Part 9: Stereochemistry in Drug Discovery and Development Read More »

Ibuprofen

Ibuprofen is a widely used non-steroidal anti-inflammatory drug (NSAID). It is a monocarboxylic acid that is propionic acid in which one of the hydrogens at position 2 is substituted by a 4-(2-methylpropyl)phenyl group. Hence belongs to the propionic acid derivative class of NSAIDs. It is commonly prescribed for pain, inflammation, and fever. Available as over-the-counter (OTC) and prescription medication worldwide. Chirality and Biological Activity Structurally, Ibuprofen is a chiral molecule with one stereogenic center at the α-position …

Ibuprofen Read More »

Part 8: Stereochemistry in Biologics and Natural Products

“Nature’s stereochemists – chirality in biologics, peptides, and natural products” Introduction Stereochemistry is inherent in biological macromolecules and natural products. This part explores chirality beyond small synthetic drugs – specifically, in biologics (peptides, proteins, nucleic acids) and in natural product-derived drugs. We examine how nature’s biosynthetic machinery imparts stereochemistry with high fidelity (e.g., enzymes produce single enantiomers of amino acids, sugars, complex polyketides). We discuss examples of drugs that are derived from natural chirality (like …

Part 8: Stereochemistry in Biologics and Natural Products Read More »

Part 5: Stereoselective and Stereospecific Synthesis

“Crafting molecules with precision – the art of stereochemical synthesis” Introduction Having seen why the correct stereochemistry is crucial for drug efficacy and safety, the next challenge is how to obtain the desired stereoisomer. This part covers strategies and methods in stereoselective and stereospecific synthesis. We clarify the terminology: a stereoselective reaction preferentially yields one stereoisomer over others (e.g., one enantiomer or one diastereomer is favored), whereas a stereospecific reaction produces different stereoisomeric products from …

Part 5: Stereoselective and Stereospecific Synthesis Read More »

Part 4: Stereochemistry in Drug Action and Pharmacology

“Why one enantiomer heals while the other may harm – the pharmacology of chirality” Introduction Chirality doesn’t just influence drug properties in theory – it has very real consequences in pharmacology. In this section, we explore how stereochemistry affects drug action at multiple levels: pharmacodynamics (drug-receptor interactions) and pharmacokinetics (absorption, distribution, metabolism, excretion). We will define terms like eutomer (the more active enantiomer) and distomer (the less active one) and introduce the concept of the …

Part 4: Stereochemistry in Drug Action and Pharmacology Read More »

Part 3: Nomenclature and Configuration

“Decoding the rules: how chemists name and navigate molecular twists.” Introduction Correctly describing the stereochemistry of a molecule is as important as understanding it. In this part, we focus on the Cahn–Ingold–Prelog (CIP) system, which provides the rules for unambiguous assignment of absolute configuration at stereocenters (R/S) and for double bond geometry (E/Z) system. We will outline the CIP priority rules step-by-step and demonstrate how to apply them to pharmaceutical molecules. Additionally, we will discuss …

Part 3: Nomenclature and Configuration Read More »

Part 1: Introduction to Stereochemistry

“The 3D language of molecules – why stereochemistry is the hidden key in drug science.” Introduction Stereochemistry is the branch of chemistry concerned with the three-dimensional arrangement of atoms in molecules and how this spatial arrangement influences chemical behavior. The term “chirality” (from the Greek cheir meaning hand) describes the property of an object or molecule that is non-superimposable on its mirror image – much like one’s left and right hands. A molecule that exhibits …

Part 1: Introduction to Stereochemistry Read More »

Mapping Stereochemical Nomenclature: A Chiralpedia Guide

Stereochemistry, the study of spatial arrangements of atoms in molecules, demands a precise and universally accepted nomenclature system. Unlike simple chemical formulas, which only indicate connectivity, stereochemical nomenclature conveys three-dimensional information essential for understanding molecular behavior, biological interactions, and pharmaceutical effects. Several systems have been developed to capture these subtle but critical differences. 🔬✨ Stereochemical Nomenclature System — Now in a Visual Story! Stereochemical naming systems are often tucked away in textbooks 📚, dense and …

Mapping Stereochemical Nomenclature: A Chiralpedia Guide Read More »

The Thalidomide Paradox

Synopsis The thalidomide tragedy is one of the most infamous episodes in pharmaceutical history—yet its stereochemical secrets are still being unraveled. A fascinating article by Tokunaga E, Yamamoto T, Ito E, and Shibata N., published in Scientific Reports (Nature Research, 2018; https://www.nature.com/articles/s41598-018-35457-6), sheds new light on the phenomenon through the lens of the self-disproportionation of enantiomers, the physical chemistry of chirality. Thalidomide’s tragic past is linked to its two “mirror-image” forms. One form, the S-enantiomer, …

The Thalidomide Paradox Read More »